WIN2016 is the 8^th edition of a successful series of symposia organized by the Worldwide Innovative Networking (WIN) Consortium, dedicated to advancing precision cancer medicine through global collaboration. This year WIN has chosen to address the critical question facing cancer research: How innovative use of targeted therapies can improve survival of greater numbers of cancer patients?

FUSCC is a member of WIN. A team of 5 persons, headed by Ms. LU Lilang, Vice President of FUSCC attended the conference in Paris from June 26^th to 28^th. The WIN Symposium presented a unique opportunity by bringing together a forum of world-class experts from different backgrounds including academic and industry, patient advocacies to address contemporary challenges and controversies around the next innovative steps in cancer therapy that will significantly improve patient’s outcomes.